Industry News
Alchemia gaining US share for anticoagulant
US sales of generic fondaparinux, the anticoagulant produced by Alchemia (ASX:ACL), are expected to have grown 120% year-on-year. [ + ]
Bee research breakthrough might lead to artificial vision
An international research breakthrough with bees means machines might soon be able to see almost as well as humans. [ + ]
Scientists develop better technique for creating self-cleaning fabrics
A new coating technique that can make fabrics ‘self-cleaning’ has been developed by Deakin University scientists. The technique creates a fabric coating that repels water, dirt, grease and other materials. [ + ]
Feature: Inside the bacterial machine
Professor Trevor Lithgow is tinkering with the cogs of bacteria to understand how they, and their mitochondrial cousins, tick. [ + ]
IPO-bound Ventus Medical eyes market growth
Ventus Medical plans to use the proceeds of its upcoming ASX IPO to fund efforts to build a market for its sleep disorder breathing products. [ + ]
Phosphagenics lands retail deal with David Jones
Retail chain David Jones has agreed to stock the Elixia range of skincare products from Melbourne-based Phosphagenics (ASX:POH). [ + ]
New vaccine shows promise to protect against common cause of meningitis
Researchers are an important step closer to finding a vaccine that protects against a wide range of strains of meningococcal B - the most common cause of meningococcal disease in Western Australia. [ + ]
Italian researchers make a major discovery into a common form of muscular dystrophy
A new study, published in the international scientific journal Cell, has identified that a novel defect in gene regulation, never before seen in a human disease, is the cause of one of the most common forms of muscular dystrophy: Facioscapulohumeral muscular dystrophy (FSHD). [ + ]
AusBiotech investment mission to sign MOU with HKBIO
An AusBiotech investment mission to Hong Kong later this month will culminate in the signing of a memorandum of understanding (MOU) between AusBiotech and the Hong Kong Biotechnology Organization (HKBIO) to boost biotechnology development. [ + ]
CathRx looks to delist from ASX
Cardiac catheter company CathRx (ASX:CXD) will likely seek shareholder approval to go private after it raises funds to pursue a potential sale of the company. [ + ]
BioDiem, VIVALIS team for viral vector research
BioDiem (ASX:BDM) and France's VIVALIS are exploring the feasibility of using BioDiem's LAIV flu virus to create a viral vector for non-influenza vaccines. [ + ]
Science and biotech survive surplus budget
Despite a budget riddled with cuts, funding for science has increased and the recently-passed R&D Tax Incentive has remained intact. [ + ]
Gillard government investing in world-class science and research
The Gillard government intends to secure Australia’s competitive economic edge by boosting funding for science and research in universities by more than $126 million in 2012-13. [ + ]
Crop root study to boost Australian grain production
Researchers at The University of Western Australia (UWA) say the ‘next frontier’ of agricultural science is understanding the root system and function of crop plants to significantly increase Australian grain production, keep farms viable and help continue to feed the world despite the onset of increasing drought and climate change. [ + ]
Flu license fees nothing to sneeze at for BioDiem
BioDiem (ASX:BDM) has received license fees totalling around 10% of its market cap from its LAIV flu vaccine technology. [ + ]
